Sökning: onr:"swepub:oai:DiVA.org:uu-54197" >
Tetanus immunity in...
Tetanus immunity in patients with hematological malignancies
-
Hammarström, Viera (författare)
-
- Pauksen, Karlis (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Friman, infektion
-
Svensson, H. (författare)
-
visa fler...
-
Öberg, G. (författare)
-
- Paul, C. (författare)
- Karolinska Institutet
-
- Ljungman, P. (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- Springer Science and Business Media LLC, 1998
- 1998
- Engelska.
-
Ingår i: Supportive Care in Cancer. - : Springer Science and Business Media LLC. - 0941-4355 .- 1433-7339. ; 6:5, s. 469-472
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
http://kipublication...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The aim of this study was to investigate long-term immunity to tetanus toxoid among patients with hematological disease who had been treated with conventional doses of chemotherapy. Altogether 206 patients with different hematological malignancies were included in the study. There were marked differences between the rates of seronegativity against tetanus, varying from 20% to 70% in different groups of study patients. We found that 21 of 80 (36%) patients with AML, 45 of 80 (56%) with ALL, 12 of 22 (54%) with lymphoma, 4 of 13 (31%) with myeloma and 2 of 11 (18%) with CML were not immune to tetanus. In a multivariate logistic regression model increasing age (P = 0.0001), lymphoid malignancy (P = 0.0005) and advanced disease stage (P = 0.0001) were independent risk factors for loss of tetanus immunity in patients with hematological malignancies.
Nyckelord
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas